Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women

Journal of Clinical Microbiology

Volumn 44, Issue 12, 2006, Pages 4479-4485

  Fakhry, Carole ^a   D'souza, Gypsyamber ^b   Sugar, Elizabeth ^a   Weber, Kathleen ^c   Goshu, Eleni ^b   Minkoff, Howard ^d   Wright, Rodney ^e   Seaberg, Eric ^b   Gillison, Maura ^a,f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Jr Hospital of Cook County   (United States)

^d MAIMONIDES MEDICAL CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBULIN; GENOMIC DNA; PRIMER DNA; VIRUS DNA;

ADULT; ARTICLE; CERVICAL HUMAN PAPILLOMAVIRUS INFECTION; CERVICAL VAGINAL LAVAGE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DOT HYBRIDIZATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOUTH CAVITY; ORAL HUMAN PAPILLOMAVIRUS INFECTION; ORAL RINSE; OROPHARYNX CANCER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVERSE LINE BLOT HYBRIDIZATION; SAMPLE; SAMPLING; UTERINE CERVIX CANCER; VAGINAL LAVAGE; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

CERVIX UTERI; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; MOUTH; MOUTH DISEASES; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVICAL DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 33845562608     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01321-06     Document Type: Article

References (36)

1. Badaracco, G., A. Venuti, A. Di Lonardo, G. Scambia, S. Mozzetti, P. Benedetti Panici, S. Mancuso, and M. L. Marcante. 1998. Concurrent HPV infection in oral and genital mucosa. J. Oral Pathol. Med. 27:130-134.
2. Barkan, S. E., S. L. Melnick, S. Preston-Martin, K. Weber, L. A. Kalish, P. Miotti, M. Young, R. Greenblatt, H. Sacks, J. Feldman, et al. 1998. The Women's Interagency HIV Study. Epidemiology 9:117-125.
3. Bosch, F., A. Lorincz, N. Munoz, C. Meijer, and K. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
4. Cameron, J. E., D. Mercante, M. O'Brien, A. M. Gaffga, J. E. Leigh, P. L. Fidel, Jr., and M. E. Hagensee. 2005. The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex. Transm. Dis. 32:703-709.
5. Cañadas, M. P., F. X. Bosch, M. L. Junquera, M. Ejarque, R. Font, E. Ordonez, and S. de Sanjose. 2004. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J. Clin. Microbiol. 42:1330-1332.
6. Castellsague, X., and N. Munoz. 2003. Chapter 3. Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J. Natl. Cancer Inst. Monogr. 2003:20-28.
7. Castle, P. E., M. Schiffman, R. Herrero, A. Hildesheim, A. C. Rodriguez, M. C. Bratti, M. E. Sherman, S. Wacholder, R. Tarone, and R. D. Burk. 2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J. Infect. Dis. 191:1808-1816.
8. Coutlée, F., A. M. Trottier, G. Ghattas, R. Leduc, E. Toma, G. Sanche, I. Rodrigues, B. Turmel, G. Allaire, and P. Ghadirian. 1997. Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex. Transm. Dis. 24:23-31.
9. D'Souza, G., E. Sugar, W. Ruby, P. Gravitt, and M. Gillison. 2005. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J. Clin. Microbiol. 43:5526-5535.
10. Frisch, M., R. J. Biggar, E. A. Engels, and J. J. Goedert. 2001. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736-1745.
11. Gillison, M. L. 2004. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin. Oncol. 31:744-754.
12. Giuliano, A. R., R. L. Sedjo, D. J. Roe, R. Harri, S. Baldwi, M. R. Papenfuss, M. Abrahamsen, and P. Inserra. 2002. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control 13:839-846.
13. Gravitt, P. E., J. V. Lacey, Jr., L. A. Brinton, W. A. Barnes, J. R. Kornegay, M. D. Greenberg, S. M. Greene, O. C. Hadjimichael, L. McGowan, R. Mortel, P. E. Schwartz, R. Zaino, and A. Hildesheim. 2001. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol. Biomarkers Prev. 10:95-100.
14. Gravitt, P. E., C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlee, A. Hildesheim, M. H. Schiffman, D. R. Scott, and R. J. Apple. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
15. Gravitt, P. E., C. L. Peyton, R. J. Apple, and C. M. Wheeler. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:3020-3027.
16. Greenspan, D., E. M. de Villiers, J. S. Greenspan, Y. G. de Souza, and H. zur Hausen. 1988. Unusual HPV types in oral warts in association with HIV infection. J. Oral Pathol. 17:482-488.
17. Hansson, B. G., K. Rosenquist, A. Antonsson, J. Wennerberg, E. B. Schildt, A. Bladstrom, and G. Andersson. 2005. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 125:1337-1344.
18. Reference deleted.
19. Reference deleted.
20. Jones, C. 1995. Cervical cancer: is herpes simplex virus type II a cofactor? Clin. Microbiol. Rev. 8:549-556.
21. Kellokoski, J. K., S. M. Syrjanen, F. Chang, M. Yliskoski, and K. J. Syrjanen. 1992. Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections. J. Oral Pathol. Med. 21:459-464.
22. Kreimer, A. R., A. J. Alberg, R. Daniel, P. E. Gravitt, R. Viscidi, E. S. Garrett, K. V. Shah, and M. L. Gillison. 2004. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J. Infect. Dis. 189:686-698.
23. Madeleine, M. M., J. R. Daling, S. M. Schwartz, K. Shera, B. McKnight, J. J. Carter, G. C. Wipf, C. W. Critchlow, J. K. McDougall, P. Porter, and D. A. Galloway. 2001. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol. Biomarkers Prev. 10:171-177.
24. Minkoff, H., J. G. Feldman, H. D. Strickler, D. H. Watts, M. C. Bacon, A. Levine, J. M. Palefsky, R. Burk, M. H. Cohen, and K. Anastos. 2004. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women. J. Infect. Dis. 189:1821-1828.
25. Mork, J., A. K. Lie, E. Glattre, G. Hallmans, E. Jellum, P. Koskela, B. Moller, E. Pukkala, J. T. Schiller, L. Youngman, M. Lehtinen, and J. Dillner. 2001. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 344:1125-1131.
26. Muñoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Merjer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
27. Muñoz, N., S. Franceschi, C. Bosetti, V. Moreno, R. Herrero, J. S. Smith, K. V. Shah, C. J. Meijer, and F. X. Bosch. 2002. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093-1101.
28. Peyton, C. L., P. E. Gravitt, W. C. Hunt, R. S. Hundley, M. Zhao, R. J. Apple, and C. M. Wheeler. 2001. Determinants of genital human papillomavirus detection in a US population. J. Infect. Dis. 183:1554-1564.
29. Samoff, E., E. H. Koumans, L. E. Markowitz, M. Sternberg, M. K. Sawyer, D. Swan, J. R. Papp, C. M. Black, and E. R. Unger. 2005. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am. J. Epidemiol. 162:668-675.
30. Schiffman, M., R. Herrero, R. Desalle, A. Hildesheim, S. Wacholder, A. C. Rodriguez, M. C. Bratti, M. E. Sherman, J. Morales, D. Guillen, M. Alfaro, M. Hutchinson, T. C. Wright, D. Solomon, Z. Chen, J. Schussler, P. E. Castle, and R. D. Burk. 2005. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76-84.
31. Schwartz, S. M., J. R. Daling, D. R. Doody, G. C. Wipf, J. J. Carter, M. M. Madeleine, E. J. Mao, E. D. Fitzgibbons, S. Huang, A. M. Beckmann, J. K. McDougall, and D. A. Galloway. 1998. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J. Natl. Cancer Inst. 90:1626-1636.
32. Silins, I., W. Ryd, A. Strand, G. Wadell, S. Tornberg, B. G. Hansson, X. Wang, L. Arnheim, V. Dahl, D. Bremell, K. Persson, J. Dillner, and E. Rylander. 2005. Chlamydia trachomatis infection and persistence of human papillomavirus. Int. J. Cancer 116:110-115.
33. Smith, E. M., J. M. Ritchie, K. F. Summersgill, H. T. Hoffman, D. H. Wang, T. H. Haugen, and L. P. Turek. 2004. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J. Natl. Cancer Inst. 96:449-455.
34. Smith, J. S., R. Herrero, C. Bosetti, N. Munoz, F. X. Bosch, J. Eluf-Neto, X. Castellsague, C. J. Meijer, A. J. Van den Brule, S. Franceschi, and R. Ashley. 2002. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J. Natl. Cancer Inst. 94:1604-1613.
35. Strickler, H. D., R. D. Burk, M. Fazzari, K. Anastos, H. Minkoff, L. S. Massad, C. Hall, M. Bacon, A. M. Levine, D. H. Watts, M. J. Silverberg, X. Xue, N. F. Schlecht, S. Melnick, and J. M. Palefsky. 2005. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J. Natl. Cancer Inst. 97:577-586.
36. Völter, C., Y. He, H. Delius, A. Roy-Burman, J. S. Greenspan, D. Greenspan, and E. M. de Villiers. 1996. Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int. J. Cancer 66:453-456.